Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term SOBI003 Extension Study in Pediatric MPS IIIA
NCT03811028Phase 2Completed
- Sponsor
- Sobi
- Start
- Jan 2019
- Primary completion
- Apr 2021
- Modality
- Replacement Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of SOBI-003 in mucopolysaccharidosis type III A, sponsored by Sobi. Started Jan 2019; status: completed.
02
Drugs
SOBI-003
03
Conditions
mucopolysaccharidosis type III A
Beyond the preview
Go deeper on NCT03811028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03811028.